An initial simple multiple biomarker strategy comprised of CRP, D-dimer and hs-TnI demonstrated promising results for estimating the risk of death and ICU admission in patients hospitalized with COVID-19, although the influence of underlying age differences cannot be excluded. This evidence concerns the gene CRP and COVID-19.